Theralase Technologies Inc. | Cash Flow
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,152.20
2,587.50
5,208.10
4,921.20
6,093.60
3,356.90
Depreciation, Depletion & Amortization
77.50
82.90
135.00
149.30
253.90
222.90
Other Funds
134.10
208.60
513.40
464.20
508.20
186.90
Funds from Operations
940.70
2,296.00
4,559.80
4,307.70
5,331.50
2,947.10
Changes in Working Capital
24.00
1,329.20
484.30
572.70
1,071.60
1,731.40
Net Operating Cash Flow
916.70
3,625.20
5,044.10
4,880.40
4,259.90
1,215.70
Capital Expenditures
93.30
114.10
248.50
296.20
410.40
Sale of Fixed Assets & Businesses
0.80
-
-
1.60
0.00
Net Investing Cash Flow
92.50
114.10
248.50
294.60
410.40
Issuance/Reduction of Debt, Net
74.40
28.60
-
-
-
Net Financing Cash Flow
2,755.50
3,893.50
7,711.00
3,804.30
1,953.90
Net Change in Cash
1,746.40
154.10
2,418.40
1,370.70
2,716.30
Free Cash Flow
1,010.00
3,739.40
5,292.60
5,176.60
4,670.20
Change in Capital Stock
2,829.90
3,922.10
7,711.00
3,804.30
1,953.90
About Theralase Technologies
View Profile
